UnitedHealth Group Inc (UNH) Receives $280.36 Consensus PT from Analysts

Share on StockTwits

Shares of UnitedHealth Group Inc (NYSE:UNH) have been given a consensus recommendation of “Buy” by the twenty-five brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, twenty-two have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $280.36.

UNH has been the topic of a number of research analyst reports. Citigroup lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price target on the stock. in a report on Monday, September 10th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. Raymond James raised their price target on UnitedHealth Group from $285.00 to $304.00 and gave the company a “strong-buy” rating in a report on Monday, September 24th. Morgan Stanley raised their price target on UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a report on Wednesday, September 5th. Finally, ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th.

Shares of UNH opened at $259.61 on Wednesday. The firm has a market cap of $256.06 billion, a PE ratio of 25.78, a price-to-earnings-growth ratio of 1.58 and a beta of 0.73. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63. UnitedHealth Group has a one year low of $186.00 and a one year high of $272.07.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, beating analysts’ consensus estimates of $3.04 by $0.10. The company had revenue of $56.09 billion for the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The company’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same period last year, the company earned $2.46 earnings per share. Sell-side analysts anticipate that UnitedHealth Group will post 12.72 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date of this dividend was Thursday, September 6th. UnitedHealth Group’s payout ratio is currently 35.75%.

In related news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Steven H. Nelson sold 8,142 shares of UnitedHealth Group stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.00, for a total value of $2,157,630.00. Following the transaction, the chief executive officer now directly owns 22,496 shares in the company, valued at $5,961,440. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 94,745 shares of company stock worth $24,995,290. 0.87% of the stock is owned by corporate insiders.

Large investors have recently added to or reduced their stakes in the stock. Welch Group LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $106,000. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group in the second quarter valued at about $107,000. Northwest Wealth Management LLC bought a new stake in UnitedHealth Group in the second quarter valued at about $117,000. Fort L.P. bought a new stake in UnitedHealth Group in the second quarter valued at about $119,000. Finally, Stelac Advisory Services LLC bought a new stake in UnitedHealth Group in the first quarter valued at about $163,000. Institutional investors and hedge funds own 85.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Fundamental Analysis – How It Helps Investors

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply